HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valter Torri Selected Research

dorzolamide (Trusopt)

10/2018The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results.
11/2017The Glaucoma Italian Pediatric Study (GIPSy): 1-Year Results.
1/2016Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics.
3/2007Central corneal thickness in the European Glaucoma Prevention Study.
3/2005Results of the European Glaucoma Prevention Study.
9/2002The European glaucoma prevention study design and baseline description of the participants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valter Torri Research Topics

Disease

33Neoplasms (Cancer)
08/2022 - 01/2003
23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2020 - 02/2003
13Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 09/2005
10Breast Neoplasms (Breast Cancer)
02/2020 - 04/2008
8Neoplasm Metastasis (Metastasis)
01/2022 - 09/2005
8Carcinoma (Carcinomatosis)
01/2018 - 05/2002
7Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2003
7Disease Progression
12/2020 - 01/2011
7Glaucoma
10/2018 - 09/2002
6Colonic Neoplasms (Colon Cancer)
12/2020 - 05/2003
4COVID-19
08/2022 - 01/2020
4Rectal Neoplasms (Rectal Cancer)
07/2020 - 12/2019
4Adenocarcinoma
01/2018 - 05/2002
4Stomach Neoplasms (Stomach Cancer)
09/2017 - 02/2006
4Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2011 - 09/2002
4Ocular Hypertension (Glaucoma, Suspect)
08/2007 - 09/2002
3Ovarian Epithelial Carcinoma
01/2022 - 01/2003
3Triple Negative Breast Neoplasms
01/2019 - 06/2014
3Lung Neoplasms (Lung Cancer)
01/2019 - 02/2014
3Lymphoma (Lymphomas)
11/2017 - 05/2016
3Exanthema (Rash)
06/2016 - 10/2011
3Acromegaly
03/2016 - 05/2009
3Prostatic Neoplasms (Prostate Cancer)
10/2015 - 06/2005
2Glioma (Gliomas)
01/2022 - 01/2018
2Malignant Mesothelioma
01/2021 - 03/2014
2Adenocarcinoma of Lung
01/2020 - 01/2019
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020 - 01/2011
2Fatigue
01/2020 - 06/2016
2Hypertension (High Blood Pressure)
01/2020 - 01/2017
2Motor Neuron Disease (Primary Lateral Sclerosis)
01/2020 - 01/2011
2Asthenia
01/2020 - 09/2013
2Glioblastoma (Glioblastoma Multiforme)
05/2019 - 01/2018
2Hemorrhage
01/2017 - 08/2007
2Sudden Death
01/2017 - 01/2015
2Chronic Kidney Failure (Chronic Renal Failure)
01/2017 - 01/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2017 - 10/2015
2Diarrhea
05/2015 - 03/2008
2Renal Cell Carcinoma (Grawitz Tumor)
06/2014 - 05/2014
2Neutropenia
06/2014 - 01/2012
2Endometrial Neoplasms (Endometrial Cancer)
04/2014 - 12/2008
2Pain (Aches)
01/2013 - 02/2006
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2011 - 11/2010
2Cancer Pain
10/2009 - 02/2006
2Lymphatic Metastasis
12/2008 - 04/2007
1Infections
08/2022

Drug/Important Bio-Agent (IBA)

8PlatinumIBA
01/2022 - 01/2003
7Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 02/2003
7Biomarkers (Surrogate Marker)IBA
07/2020 - 09/2004
7ErbB Receptors (EGF Receptor)IBA
10/2019 - 09/2004
7Cisplatin (Platino)FDA LinkGeneric
01/2019 - 05/2003
7Fluorouracil (Carac)FDA LinkGeneric
07/2010 - 05/2003
6Trastuzumab (Herceptin)FDA Link
12/2020 - 04/2009
6Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 09/2013
6dorzolamide (Trusopt)FDA LinkGeneric
10/2018 - 09/2002
5Bevacizumab (Avastin)FDA Link
10/2019 - 03/2007
5Tyrosine Kinase InhibitorsIBA
05/2014 - 07/2009
5Leucovorin (Folinic Acid)FDA Link
10/2008 - 05/2004
4Lapatinib (GW572016)FDA Link
12/2020 - 12/2015
4Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2002
4Immune Checkpoint InhibitorsIBA
12/2019 - 01/2019
4Carboplatin (JM8)FDA LinkGeneric
10/2019 - 02/2003
4Rituximab (Mabthera)FDA Link
11/2017 - 05/2016
3TrabectedinIBA
01/2021 - 01/2018
3Biological ProductsIBA
01/2019 - 11/2010
3Latanoprost (Xalatan)FDA Link
10/2018 - 01/2016
3Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2018 - 09/2005
3Cetuximab (Erbitux)FDA Link
06/2016 - 05/2008
3AfatinibIBA
12/2015 - 02/2014
3Gefitinib (Iressa)FDA Link
05/2015 - 09/2004
2C-Reactive ProteinIBA
01/2022 - 01/2020
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2021
2Monoclonal AntibodiesIBA
01/2021 - 12/2015
2pertuzumabIBA
12/2020 - 01/2020
2MicroRNAs (MicroRNA)IBA
07/2020 - 06/2020
2Pharmaceutical PreparationsIBA
01/2020 - 10/2015
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
12/2019 - 10/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 05/2003
2Hormones (Hormone)IBA
01/2019 - 01/2006
2Vinorelbine (Navelbine)FDA LinkGeneric
01/2019 - 01/2017
2Contrast MediaIBA
01/2018 - 05/2009
2Methotrexate (Mexate)FDA LinkGeneric
11/2017 - 05/2016
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
11/2017 - 05/2016
2Cytarabine (Cytosar-U)FDA LinkGeneric
11/2017 - 05/2016
2Chlorambucil (Leukeran)FDA Link
06/2017 - 01/2017
2Docetaxel (Taxotere)FDA Link
01/2017 - 09/2013
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2012 - 05/2009
2Anti-Bacterial Agents (Antibiotics)IBA
09/2011 - 10/2009
2IfosfamideFDA LinkGeneric
06/2005 - 02/2003

Therapy/Procedure

34Drug Therapy (Chemotherapy)
01/2022 - 01/2003
23Therapeutics
08/2022 - 06/2005
9Adjuvant Chemotherapy
12/2020 - 01/2003
8Radiotherapy
12/2019 - 01/2003
6Neoadjuvant Therapy
07/2020 - 06/2005
3Immunotherapy
01/2021 - 12/2019
2Minimally Invasive Surgical Procedures
01/2020 - 12/2019
2Critical Care (Surgical Intensive Care)
01/2020 - 10/2009
2Aftercare (After-Treatment)
01/2019 - 12/2012
2Stem Cell Transplantation
11/2017 - 05/2016
2Renal Dialysis (Hemodialysis)
01/2017 - 10/2011
2Lymph Node Excision (Lymph Node Dissection)
04/2014 - 12/2008